DEVELOPMENT OF A NOVEL ZIRCONIUM-89 LABELLED ANTIBODY FOR IMAGING PD-L1 DYNAMICS IN MICE MESOTHELIOMA

被引：0
|
作者：
Mohamed, Shifaza [1 ]
机构：
[1] Sir Charles Gairdner Hosp, Nedlands, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [31] A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
    Chatterjee, Samit
    Lesniak, Wojciech G.
    Gabrielson, Matthew
    Lisok, Ala
    Wharram, Bryan
    Sysa-Shah, Polina
    Azad, Babak Behnam
    Pomper, Martin G.
    Nimmagadda, Sridhar
    ONCOTARGET, 2016, 7 (09) : 10215 - 10227
  • [32] Targeting the intrinsic signaling of PD-L1 in human monocytes by a novel PD-L1 antibody to promote anti-tumor immunity.
    Hsu, Michelle A.
    Liu, Xin
    Barham, Whitney
    Hirdler, Jacob
    Mao, Zhiming
    Lucien, Fabrice
    Dong, Haidong
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [33] Noninvasive imaging of the PD-1/PD-L1 checkpoint in naive mice and after combined radioimmunotherapy
    Hettich, M.
    Braun, F.
    Niedermann, G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S249 - S249
  • [34] A novel form of immunotherapy using antigen peptides conjugated on PD-L1 antibody
    Lee, Eun Ji
    Jang, Gun-Young
    Lee, Sung Eun
    Lee, Ji won
    Han, Hee Dong
    Park, Yeong-Min
    Kang, Tae Heung
    IMMUNOLOGY LETTERS, 2021, 240 : 137 - 148
  • [35] Development of a Bispecific Antibody 124I-NB12 for Imaging PD-L1/2 Expression in Tumors
    Yao, Y.
    Li, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S189 - S189
  • [36] Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of 89Zr-Labeled Anti-PD-L1 Antibody Formats
    Bouleau, Alizee
    Nozach, Herve
    Dubois, Steven
    Kereselidze, Dimitri
    Chevaleyre, Celine
    Wang, Cheng-, I
    Evans, Michael J.
    Lebon, Vincent
    Maillere, Bernard
    Truillet, Charles
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) : 1259 - 1265
  • [37] Development of Novel Small Antitumor Compounds Inhibiting PD-1/PD-L1 Binding
    Akiyama, Yasuto
    Ashizawa, Tadashi
    Iizuka, Akira
    Ando, Takayuki
    Ishikawa, Yoshinobu
    Kondou, Ryota
    Miyata, Haruo
    Maeda, Haruo
    Kanematsu, Akari
    Sugino, Takashi
    Yamaguchi, Ken
    ANTICANCER RESEARCH, 2022, 42 (11) : 5233 - 5247
  • [38] Development of high affinity engineered antibody fragments targeting PD-L1 for immunoPET
    Nigam, Shubhanchi
    Edwards, Barry
    Edinger, Robert
    Anderson, Carolyn
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [39] A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
    Koopmans, Iris
    Hendriks, Djoke
    Samplonius, Douwe F.
    van Ginkel, Robert J.
    Heskamp, Sandra
    Wierstra, Peter J.
    Bremer, Edwin
    Helfrich, Wijnand
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [40] A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
    Koopmans, Iris
    Samplonius, Douwe F.
    van Ginkel, Robert J.
    Wierstra, Peter J.
    Heskamp, Sandra
    Bremer, Edwin
    Helfrich, Wijnand
    CANCER RESEARCH, 2018, 78 (13)
12345